These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. India's DNA COVID vaccine is a world first - more are coming. Mallapaty S Nature; 2021 Sep; 597(7875):161-162. PubMed ID: 34475553 [No Abstract] [Full Text] [Related]
4. Developing and sustaining India's capacity for preclinical drug discovery. Lewis DI; Patel BK; Kumar BD; Medhi B Indian J Pharmacol; 2018; 50(5):225-226. PubMed ID: 30636824 [No Abstract] [Full Text] [Related]
5. COVID-19 vaccine: Challenges in developing countries and India's initiatives. Chakraborty C; Ranjan Sharma A; Bhattacharya M; Lee SS; Agoramoorthy G Infez Med; 2021 Mar; 29(1):165-166. PubMed ID: 33664189 [TBL] [Abstract][Full Text] [Related]
6. How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis. Bloom DE; Cadarette D; Ferranna M; Hyer RN; Tortorice DL Health Aff (Millwood); 2021 Mar; 40(3):410-418. PubMed ID: 33539191 [TBL] [Abstract][Full Text] [Related]
7. India's growing clinical research sector: opportunity for global companies. Varawalla N IDrugs; 2007 Jun; 10(6):391-4. PubMed ID: 17642002 [TBL] [Abstract][Full Text] [Related]
8. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study. Gouglas D; Thanh Le T; Henderson K; Kaloudis A; Danielsen T; Hammersland NC; Robinson JM; Heaton PM; Røttingen JA Lancet Glob Health; 2018 Dec; 6(12):e1386-e1396. PubMed ID: 30342925 [TBL] [Abstract][Full Text] [Related]
14. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere. Heriot GS; Jamrozik E Med J Aust; 2021 Mar; 214(4):150-152.e1. PubMed ID: 33550606 [No Abstract] [Full Text] [Related]
16. [Fight against COVID-19: market overview and pipeline of ongoing trials]. Pontremoli R; Richard G; Vuddamalay G; Groux N Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647 [No Abstract] [Full Text] [Related]
17. Access considerations for a COVID-19 vaccine for South Africa. Bangalee V; Suleman F S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954 [TBL] [Abstract][Full Text] [Related]
18. India's New COVID-19 DNA Vaccine for Adolescents and Adults Is a First. Abbasi J JAMA; 2021 Oct; 326(14):1365. PubMed ID: 34636874 [No Abstract] [Full Text] [Related]
19. COVID-19: vaccination problems. Brüssow H Environ Microbiol; 2021 Jun; 23(6):2878-2890. PubMed ID: 33928745 [TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India. Du Z; Wang L; Bai Y; Feng S; Ramachandran S; Lim WW; Lau EHY; Malani A; Cowling BJ Med; 2023 Mar; 4(3):182-190.e3. PubMed ID: 36827972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]